LLS News Network

New Poll: Americans Believe It’s Time to Protect Consumers From Predatory Short-Term Health Plans

Posted On: January 24, 2022

Washington, D.C., Jan. 25, 2022 — An overwhelming majority of adults (79%) believes the government should regulate insurance products that exploit loopholes to discriminate against cancer patients and others with pre-existing conditions, according to a new national survey.

Burlington Stores’ 20th Consecutive In-Store Fundraising Campaign Raises Nearly $3.4 Million for The Leukemia & Lymphoma Society

Posted On: January 18, 2022

Funds will provide lifesaving treatments and support The LLS Children’s Initiative research pillar dedicated to pediatric cancer care innovation

LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors

Posted On: January 4, 2022

Rye Brook, N.Y., January 4, 2022 – Given the rapid rise in COVID-19 infections caused by the Omicron variant, The Leukemia & Lymphoma Society has developed this page to provide blood cancer patients and survivors with the latest information about this rapidly emerging situation.

FDA Approves First Drug for The Prevention of Acute Graft Versus Host Disease

Posted On: December 22, 2021

Rye Brook, N.Y., December 15, 2021 – The Food and Drug Administration (FDA) recently approved abatacept (Orencia), in combination with certain immunosuppressants, for the prevention of acute graft versus host disease (aGVHD) in patients 2 years and older who underwent a stem cell transplant from an unrelated donor.

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.